Gate Bioscience

Press Releases

Gate Bioscience Enters into a Collaboration and License Agreement with Lilly to Discover and Develop Molecular Gate Medicines

Collaboration combines Gate Bioscience’s Molecular Gate drug discovery engine with Lilly's expertise in small molecule therapeutics.

Continue reading →
GateBio Molecule image

Gate Bioscience

In the News

Gate Bioscience Appoints Industry Veteran Jeff Hatfield to Board of Directors

Gate Bioscience, a biotechnology company developing a new class of small molecule medicines to eliminate disease-causing proteins at their source, today announced the appointment of Jeff Hatfield to its Board of Directors.

Continue reading →
Foiling Deadly Prions

Can the course of fatal prion diseases be changed by removing the protein before it goes bad?

Continue reading →
Gate: selective blockade of pathogenic protein secretion

Gate Bio emerged from stealth with a $60M series A and a small molecule platform for selective gating of protein secretion

Continue reading →
Biotech startup taps ancient biology for new way to attack diseases

The company last year raised a $60 million Series A round led by Versant Ventures and Andreessen Horowitz and including ARCH Venture Partners and GV.

Continue reading →
‘Small molecules are sexy again’: Gate Bioscience debuts with $60M and a new way to stop disease-causing proteins

Gate Bioscience has raised $60 million to develop a new type of pill-based medicine — which it calls a molecular gate — that can go after the spectrum of malicious proteins.

Continue reading →
Gate Bioscience Emerges from Stealth and Introduces Molecular Gates

Gate Bioscience, a biotechnology company creating a new class of medicines called Molecular Gates, today unveiled the company and its scientific platform.

Continue reading →